Holen Sie sich die Stockscreener-App
8.01
4.19%
-0.35
Schlusskurs vom Vortag:
$8.36
Offen:
$8.16
24-Stunden-Volumen:
19,826
Relative Volume:
0.63
Marktkapitalisierung:
$110.75M
Einnahmen:
$49.98M
Nettoeinkommen (Verlust:
$-9.64M
KGV:
-11.28
EPS:
-0.71
Netto-Cashflow:
$-4.86M
1W Leistung:
-1.11%
1M Leistung:
-4.64%
6M Leistung:
-18.10%
1J Leistung:
+62.80%
1-Tages-Spanne:
$7.8204
$8.22
1-Wochen-Bereich:
$7.5923
$8.63
52-Wochen-Spanne:
$3.6001
$11.99
Champions Oncology Inc Stock (CSBR) Company Profile
Firmenname
Champions Oncology Inc
Sektor
Branche
Telefon
410-369-0365
Adresse
855 N. WOLFE STREET, BALTIMORE, NJ
Vergleichen Sie CSBR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CSBR
Champions Oncology Inc
|
8.01 | 112.00M | 49.98M | -9.64M | -4.86M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.81 | 120.40B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
542.52 | 61.30B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.53 | 41.06B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
564.59 | 34.29B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.55 | 27.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-12 | Hochstufung | Craig Hallum | Hold → Buy |
| 2019-11-18 | Eingeleitet | The Benchmark Company | Speculative Buy |
Champions Oncology Inc Aktie (CSBR) Neueste Nachrichten
Champions Oncology Inc. Stock Analysis and ForecastMarket-beating performance - Jammu Links News
Hygiene Limited (MHHL)High-velocity gains - Jammu Links News
What analysts say about Champions Oncology Inc. stockFree Market Volatility Navigation Tips - Jammu Links News
Jagjanani Textiles Limited (532825) Stock RalliesOutstanding capital appreciation - Jammu Links News
Top Tech Stocks for Investment Professional Stock RecommendationsBreakthrough profit margins - Jammu Links News
Humanized Mouse and Rat Model Market worth US$409.8 million in 2030 with 8.2% CAGR - openPR.com
Humanized Mouse And Rat Model Market Worth US$409.8 Million In 2030 With 8.2% CAGR - Barchart.com
Champions Oncology Names New CEO - Contract Pharma
Starteck Finance Limited (STARTECK) Gets Regulatory ApprovalSuperior trading gains - Jammu Links News
Champions Oncology Announces Appointment of New CEO - ACCESS Newswire
Champions Oncology names Rob Brainin as new CEO By Investing.com - Investing.com Canada
Champions Oncology appoints Rob Brainin as CEO - TipRanks
Champions Oncology Taps 25-Year Life Sciences Leader Rob Brainin as CEO for Strategic Data Platform Push - Stock Titan
Patient-Derived Xenograft Model Market Size at USD 1.12 Billion in 2031, Forecasted to Grow at 13.4% CAGR Through 2031 | The Insight Partners - The Malaysian Reserve
Is Sohu.com Limited Depositary Receipt stock a good hedge against inflationLow Risk Stock Strategies - Newser
CARDI(cardi drc 20) Tokenomics ExplainedFree Risk Assessment Services - Newser
Top Reasons to Buy MINIBNBTIGER(minibnbtiger)Top Momentum Stock Pick - Newser
Why FirstSun Capital Bancorp stock attracts strong analyst attentionMassive Upside Selection - Newser
How Champions Oncology Inc. stock performs during market volatilityTriple Digit Return Forecasts - Newser
Why Ring Energy Inc. stock attracts strong analyst attentionFree Access to Community - Newser
What makes Champions Oncology Inc. stock price move sharplyFree Best Performing Stock Alerts - Newser
Why Champions Oncology Inc. stock attracts strong analyst attentionReal Time Stock Signal - Newser
How EBON stock performs during market volatilityRisk Managed Trading Strategy - Newser
How Gladstone Commercial Corporation Preferred Security stock performs during market volatilityTop Rated Trade Entries - Newser
How ZW Data Action Technologies Inc. stock performs during market volatilityDaily Price Surge List - Newser
Why BOB(build on bnb) Will ExplodeCapital Growth Picks - Newser
What makes INKT stock price move sharplyFree Elite Traders Group - Newser
Why ESSA Pharma Inc. stock attracts strong analyst attentionWeekly Double Return List - Newser
How Blackstone Inc. stock performs during market volatilityProfessional Stock Screener - Newser
Why LGMK stock attracts strong analyst attentionConsistent High Return Strategy - Newser
Why High Roller Technologies Inc. stock attracts strong analyst attentionInvestor Friendly Risk Reward - Newser
When UBSI stock expected to show significant growthIs SGRY stock a good long term investment option5x Profit Potential - Newser
How Omega Healthcare Investors Inc. stock performs during market volatilityWeekly Big Movers - Newser
Why Olympic Steel Inc. stock attracts strong analyst attentionSafety First Trading Signals - Newser
How Gilead Sciences Inc. stock performs during market volatilityFree Stock Market Knowledge Sharing - Newser
What makes Superior Group of Companies Inc. stock price move sharplyFree Stock Trading Community - Newser
Why SONDW stock attracts strong analyst attentionHigh Return Intraday Picks - Newser
How OTIS stock performs during market volatilityLong Term Safe Yield Focus - Newser
AGFA HealthCare Achieves HITRUST I1 Certification, Demonstrating Its Commitment to and Compliance With Data Protection Standards, and Protecting Against Cybersecurity Threats - NTB Kommunikasjon
Press-Releases - Western Morning News
Colorectal Cancer Treatment Market Size is Projected to Reach USD 24.77 Billion, with a Robust 3.2% CAGR till 2031, Rising Prevalence of Cancer Boosts | The Insight Partners - The Malaysian Reserve
Champions oncology launches radiopharmaceutical services platform By Investing.com - Investing.com Canada
Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models - ACCESS Newswire
Champions Oncology Launches Advanced Radiopharmaceutical Platform with 30+ PDX Models | CSBR Stock News - Stock Titan
Champions Oncology, Inc.'s (NASDAQ:CSBR) Shares Leap 29% Yet They're Still Not Telling The Full Story - simplywall.st
Polaris Renewable Energy Announces Q1 2025 Investor Call Details - Via Ritzau
Unlocking a First-in-Class EGFR/HER3 ADC: Sichuan Biokin's Iza-Bren Poised to Transform Oncology Markets - AInvest
(CSBR) Trading Advice - news.stocktradersdaily.com
Merus N.V. (MRUS): A Breakthrough in Oncology with Petosemtamab's ASCO-Backed Potential - AInvest
Tumor Mice Model Market Trends, Analysis, and Forecast - GlobeNewswire
Global Financial Institutions and Technology Leaders Collaborate Under FINOS to Launch Open Source Common Controls for AI Services - NTB Kommunikasjon
Finanzdaten der Champions Oncology Inc-Aktie (CSBR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):